Sell GE HealthCare Stock, UBS Says. The Risks Aren’t Known.

UBS has issued a 'Sell' rating on GE HealthCare stock, citing a lack of clarity around potential risks that could impact the company's future performance. The investment bank believes that an insufficient understanding of these unknown factors makes the stock a less attractive investment at its current valuation.